New York Times, October 29, 2010. FDA requested the company provide thorough evaluation of the drug’s potential for causing birth defects and heart problems.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Glaxo’s Avandia to Be Pulled From EU Market, Restricted in U.S.
Bloomberg, September 23, 2010. GlaxoSmithKline Plc‘s Avandia, once the world’s best-selling diabetes drug, will be withdrawn in Europe and restricted in the U.S. after a three-year review of the medicine’s heart risks.
Read More »Does Avandia Decision Signal New FDA? Or Same Old Agency?
NPR, September 23, 2010. The Europeans are suspending sales of the controversial diabetes drug Avandia because of evidence it may cause serious heart problems. American regulators are letting it stay on the market, with restrictions.
Read More »Medical Devices That Can Kill
Reader’s Digest, September 2010. In 2009, a study by Congress’s Government Accountability Office found that the safety and efficacy of many of the riskiest devices on the market have never been proved. The FDA’s oversight of medical products is broken.
Read More »The Effects of a Controversial Cancer Drug
Washington Post, Letters to the Editor, August 22, 2010. Research shows that breast cancer patients taking Avastin don’t live as long and they have more serious side effects than patients taking placebo. That is why Avastin should not be used for breast cancer, even if it were free.
Read More »